Read the latest news from regional and global sources, presenting different voices and perspectives.
The Minister of Health Inaugurates a Hospital in Angola Where 20 Cuban Doctors Work
14ymedio
·
November 17, 2024
The inauguration of the Comandante Raúl Díaz Argüelles general hospital in the Angolan province of Cuanza Sur / Prensa Latina 14ymedio, Havana, October 21, 2024 — The Minister of Public Health of Cuba, José Ángel Portal Miranda, inaugurated the...
Implantica Submits FDA PMA Application Clinical Module 2 For Refluxstoptm For U.S. Market Approval
MENAFN
·
November 14, 2024
(MENAFN- PR Newswire) VADUZ, Liechtenstein, Nov. 14, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStopTM for the treatment of...
Orphan designation: Autologous haematopoietic cells genetically modified with a lentiviral vector containing the human gp91(phox) gene Treatment of X-linked chronic granulomatous disease, 09/02/2012 Positive
European Medicines Agency
·
November 10, 2024
At the time of designation, X-linked CGD affected less than 0.02 in 10,000 people in the European Union (EU)*. This is equivalent to a total of fewer than 1,000 people, and is below the ceiling for orphan designation, which is 5 people in 10,000....
FDA rejects Intercept's ask for Ocaliva full nod in rare liver disease, but accelerated approval remains
Fierce Pharma
·
November 12, 2024
In the wake of an unfavorable advisory committee meeting in September, Intercept Pharmaceuticals’ bid to win full approval for its liver disease drug Ocaliva has come up short. Intercept on Tuesday revealed that it received a complete response...
Orphan designation: 2-Hydroxypropyl-β-cyclodextrin Treatment of Niemann-Pick's disease, type C, 26/04/2013 Positive
European Medicines Agency
·
October 22, 2024
At the time of designation, Niemann-Pick disease, type C affected approximately 0.1 in 10,000 people in the European Union (EU). This was equivalent to a total of around 5,000 people*, and is below the ceiling for orphan designation, which is 5...
LEO Pharma's Delgocitinib Launches for Chronic Hand Eczema in Germany
Dermatology Times
·
October 15, 2024
LEO Pharma announced today that the company has launched delgocitinib (Anzupgo) cream in Germany, making it the first country where the topical treatment will be available for adults with moderate to severe chronic hand eczema (CHE).1 The launch...
Bojan Miovski on his Rangers aims, the Aberdeen backlash and that Celtic penalty call
The Herald (Scotland)
·
September 1, 2025
Miovski worked hard from kick-off, had an appeal for an early penalty waved away by referee Don Robertson and probed the visitors’ defence tirelessly for an opening until being replaced by Cyriel Dessers midway through the second half. However,...
Conflicts of Law: Norwich Pharmacal Orders in Liechtenstein
JD Supra - California
·
November 5, 2024
In Magomedov & Others v. Kuzovkov & Others,[1] the High Court handed down an interesting decision examining the conflict of foreign criminal law with the discretion of the Courts of England and Wales to grant a Norwich Pharmacal Order (NPO). An...
Azerbaijan restricts livestock imports from EU amid disease concerns
Xinhua News Agency
·
BAKU, Nov. 4 (Xinhua) -- Azerbaijan has imposed temporary import restrictions on livestock products from certain regions in France, Liechtenstein, Italy, Romania and Austria, following reports of animal disease outbreaks, the Food Safety Agency of...
European Commission Authorizes Twice-Yearly Yeytuo® (Lenacapavir) for HIV Prevention
The AI Journal
·
August 26, 2025
– Yeytuo® is the First and Only European Commission (EC)-Authorized HIV PrEP Option Offering 6 Months of Protection – – Accelerated EC Decision Comes After U.S. FDA Approval in June – FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc....
Real World Economics: U.S. is tops, except for health care
Pioneer Press - Minnesota
·
November 3, 2024
Edward Lotterman Perceptions often clash with reality and when it comes to decisions, perceptions often hold sway. The Oct. 19 issue of The Economist, the world’s most influential news magazine, included a 16-page special report proclaiming the...
Implantica Publishes Interim Report January - June 2025 (Q2)
MENAFN
·
August 14, 2025
(MENAFN- PR Newswire) VADUZ, Liechtenstein, Aug. 14, 2025 /PRNewswire/ -- Transforming Clinical Excellence of RefluxStop® into Strategic Market Momentum Significant events in the second quarter of 2025 FDA PMA Submission Completed - Submitted...
European Commission approves LEO Pharma’s Anzupgo cream for adults with moderate to severe chronic hand eczema
Pharma Business International
·
October 2, 2024
The European Commission (EC) has granted marketing authorization for LEO Pharma’s Anzupgo (delgocitinib) cream for the treatment of adult patients with moderate to severe chronic hand eczema (CHE) for whom topical corticosteroids are inadequate or...
Gilead’s Twice-Yearly Lenacapavir Gets Positive CHMP Opinion for HIV Prevention
Pharma Journalist
·
July 28, 2025
Gilead Sciences, Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending lenacapavir, an injectable HIV-1 capsid inhibitor, for use as...
Dutch health institute still monitoring Mpox spread after infection in Germany
NL Times
·
October 22, 2024
The National Institute for Public Health and the Environment (RIVM) continues to monitor the spread of Mpox. That will not change now that the new variant of the virus has been identified for the first time in a neighboring country. On Tuesday,...
Top Pharma Trends to Watch in 2024
BioPharma Dive
·
Thank you for your interest. Oops something went wrong. READ NOW {"LSQLeadFields":[{"Seq":1,"Name":"First Name","SchemaName":"FirstName","Type":"text","CtrlType":"textbox","IsMandatory":"1","DisplayName":"First...
Ivoclar Summer School Highlights Global Collaboration
Dentistry Today
·
August 5, 2025
The Ivoclar Group, one of the world’s leading manufacturers of integrated solutions for high-quality dental applications with an extensive product and systems portfolio for dentists, dental technicians, and dental hygienists, once again...
Gilead Sciences gets European Commission marketing authorization for twice yearly Yeytuo for HIV prevention
Medical Dialogues
·
August 27, 2025
Foster City: Gilead Sciences, Inc. has received the European Commission (EC) marketing authorization for Yeytuo (lenacapavir)-the company's twice-yearly injectable HIV-1 capsid inhibitor—for use as pre-exposure prophylaxis (PrEP) to reduce the...
Take Control of Your Cash Flow: Proven Strategies for AR Leaders
CFO Dive
·
Thank you for your interest in the webinar! Check your inbox for an email with instructions on viewing this on-demand presentation. Oops something went wrong. Watch Now {"LSQLeadFields":[{"Seq":1,"Name":"First...
LEO Pharma's Anzupgo cream receives European marketing approval for adults with moderate to severe chronic hand eczema
Pharmabiz.com
·
LEO Pharma A/S, a global leader in medical dermatology, announced that the European Commission (EC) has granted marketing authorization for Anzupgo (delgocitinib) cream for the treatment of adult patients with moderate to severe chronic hand...